Elsevier

Biomedicine & Pharmacotherapy

Volume 99, March 2018, Pages 1014-1021
Biomedicine & Pharmacotherapy

Sex differences in the formation of atherosclerosis lesion in apoE-/-mice and the effect of 17β-estrodiol on protein S-nitrosylation

https://doi.org/10.1016/j.biopha.2018.01.145Get rights and content
Under a Creative Commons license
open access

Abstract

Estrogen plays aprotective effect on the cardiovascular system. Abnormal vascular smooth muscle cells (VSMCs) are involvedin the progress of atherosclerosis. However, the effect of estrogen on VSMCs is still unclear. The purpose of this study is to investigate the effect of 17β-estradiol (E2), a potent endogeneous estrogen, on the development of atherosclerosis and its potential mechanisms. In vivo, the formation of atherosclerotic lesions and the extent of protein S-nitrosylation were compared between female and male apoE−/− mice to assess the effect of estrogen. It showedthat the gross lesion area of the aorta tree, the lesion area atthe aortic root and the contents of lipids, macrophages and VSMCs were significantly less in female apoE-/- mice than those in male mice (p < 0.05). In addition, compared with male mice, plasma NO level and protein S-nitrosylation level of VSMCs were significantly higher in female mice (p < 0.01). Rat VSMCs (rVSMCs) were successfully isolated. In vitro, the levels of NO and protein S-nitrosylation in rVSMCs with E2 treatment were also assessed. The result revealed that E2 treatment reversed the ox-LDL-induced superoxide anion level increaseand the ox-LDL-induced NO and protein S-nitrosylation levels decrease in rVSMCs. Our data indicated that female is less susceptible to atherosclerosis.It might be becauseestrogenpromotes NO production and down-regulatessuperoxide anion level, which further upregulates the protein S-nitrosylation level of VSMCs against the occurrence and development of atherosclerosis.

Abbreviations

rVSMCs
rat vascular smooth muscle cells
NO
nitric oxide
ox-LDL
oxidized low-density lipoprotein
E2
17β-estradiol
ERα
estrogen receptorα
ERK
extracellular regulated protein kinases
TNF
tumor necrosis factor
NF-κB
nuclear factor κ-light-chain-enhancer of activated B cells
DMEM
Dulbecco’s modified Eagle’s medium
FBS
fetal bovine serum
H&E
hematoxylin and eosin
EVG
elastica van Gieson
FITC
Fluorescein isothiocyanate
DAPI
4,6-diamidino-phenylindole
EDTA
ethylenediaminetetraacetic acid
DHE
dihydroethidium

Keywords

Atherosclerosis
17β-estradiol
Vascular smooth muscle cells
Nitric oxide
Protein S-nitrosylation

Cited by (0)